MAPT and Alzheimer disease: This contrasts with studies emphasizing the prognostic value of asymmetry in AD [76], highlighting the need for shape asymmetry analysis [79] or multimodal approaches integrating machine learning with other advanced MRI methods or tau‐PET to disentangle clinical relevance [80, 81].